Explore more publications!
Lebanon Sci-Tech Weekly
Submit Press Release

Lebanon Sci-Tech Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Lebanon Sci-Tech Weekly.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 7, 2025

Nurix Therapeutics Presents New Translational Data from First-in-Human Clinical Trial of Oral CBL-B Inhibitor NX-1607 Demonstrating Immune Activation and Tumor Microenvironment Remodeling
November 7, 2025

Nurix Therapeutics Presents New Translational Data from First-in-Human Clinical Trial of Oral CBL-B Inhibitor NX-1607 Demonstrating Immune Activation and Tumor Microenvironment Remodeling

Indeterminate GlobeNewswire
IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
November 7, 2025

IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Indeterminate GlobeNewswire
BioAge Labs to Present at Jefferies Global Healthcare Conference in London
November 7, 2025

BioAge Labs to Present at Jefferies Global Healthcare Conference in London

Indeterminate GlobeNewswire
MiNK Therapeutics Reports Durable Responses and Immune Reactivation with Allo-iNKT Cell Therapy agenT-797 in PD-1–Refractory Solid Tumors at SITC 2025
November 7, 2025

MiNK Therapeutics Reports Durable Responses and Immune Reactivation with Allo-iNKT Cell Therapy agenT-797 in PD-1–Refractory Solid Tumors at SITC 2025

Indeterminate GlobeNewswire
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program
November 7, 2025

NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program

Indeterminate GlobeNewswire
Trained Therapeutix Demonstrates RIDE-001 Trains Myeloid Cells for Anti-Tumor Immune Response in Preclinical Data Presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 7, 2025

Trained Therapeutix Demonstrates RIDE-001 Trains Myeloid Cells for Anti-Tumor Immune Response in Preclinical Data Presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

Indeterminate GlobeNewswire
Coherus Oncology Presents at SITC Clinical Multiomic Biomarker Data for CHS-114, a Highly Selective anti-CCR8 Cytolytic Antibody
November 7, 2025

Coherus Oncology Presents at SITC Clinical Multiomic Biomarker Data for CHS-114, a Highly Selective anti-CCR8 Cytolytic Antibody

Indeterminate GlobeNewswire
Strategy Overview Named Champion of PitchIT Competition at IT Nation Connect 2025
November 7, 2025

Strategy Overview Named Champion of PitchIT Competition at IT Nation Connect 2025

Indeterminate GlobeNewswire
Draganfly to Host Shareholder Update Call on November 12, 2025
November 7, 2025

Draganfly to Host Shareholder Update Call on November 12, 2025

Indeterminate GlobeNewswire
Wearable Devices Expands into Asia’s Tech Powerhouse: Secures Exclusive Distribution Agreement in South Korea
November 7, 2025

Wearable Devices Expands into Asia’s Tech Powerhouse: Secures Exclusive Distribution Agreement in South Korea

Indeterminate GlobeNewswire
Aduro Clean Technologies unterzeichnet unverbindliche Absichtserklärung für Demonstrationsanlage in Europa
November 7, 2025

Aduro Clean Technologies unterzeichnet unverbindliche Absichtserklärung für Demonstrationsanlage in Europa

Indeterminate GlobeNewswire
Aduro Clean Technologies signe une lettre d’intention pour l’installation d’une usine de démonstration en Europe
November 7, 2025

Aduro Clean Technologies signe une lettre d’intention pour l’installation d’une usine de démonstration en Europe

Indeterminate GlobeNewswire
Neurogastrx Announces NG101 Phase 2 Clinical Study Demonstrating Significant Reductions in Nausea and Vomiting Induced by GLP-1 Receptor Agonist Semaglutide
November 7, 2025

Neurogastrx Announces NG101 Phase 2 Clinical Study Demonstrating Significant Reductions in Nausea and Vomiting Induced by GLP-1 Receptor Agonist Semaglutide

Indeterminate GlobeNewswire
Ipsen présentera, lors de deux sessions « late-breaking » au congrès de l’AASLD, de nouvelles données sur la CBP confirmant l’efficacité et la tolérance à long terme d’IQIRVO® ainsi que de nouvelles analyses sur les mécanismes sous-jacents…
November 7, 2025

Ipsen présentera, lors de deux sessions « late-breaking » au congrès de l’AASLD, de nouvelles données sur la CBP confirmant l’efficacité et la tolérance à long terme d’IQIRVO® ainsi que de nouvelles analyses sur les mécanismes sous-jacents…

Indeterminate GlobeNewswire
Lianhe Sowell International Group Ltd Announces Approval of Dual-Class Share Structure by Shareholders
November 7, 2025

Lianhe Sowell International Group Ltd Announces Approval of Dual-Class Share Structure by Shareholders

Indeterminate GlobeNewswire
Champion Safe Celebrates Hyatt Coin Shop for 30% Year-Over-Year Growth in the Southeast
November 7, 2025

Champion Safe Celebrates Hyatt Coin Shop for 30% Year-Over-Year Growth in the Southeast

Indeterminate GlobeNewswire
ODYSIGHT.AI ANNOUNCES COMMERCIAL PURCHASE ORDER FOR 200 INDUSTRIAL PREDICTIVE MONITORING SYSTEMS FOR ELEVATORS
November 7, 2025

ODYSIGHT.AI ANNOUNCES COMMERCIAL PURCHASE ORDER FOR 200 INDUSTRIAL PREDICTIVE MONITORING SYSTEMS FOR ELEVATORS

Indeterminate GlobeNewswire
New Pooled 3-Year Analysis Confirms Sustained, Clinically Meaningful Improvements in Renal Function for TransCon® PTH (Palopegteriparatide)-Treated Adults with Hypoparathyroidism
November 7, 2025

New Pooled 3-Year Analysis Confirms Sustained, Clinically Meaningful Improvements in Renal Function for TransCon® PTH (Palopegteriparatide)-Treated Adults with Hypoparathyroidism

Indeterminate GlobeNewswire
Altimmune Presents AI-Based Analysis of Liver Fibrosis Reduction from IMPACT Phase 2b Trial of Pemvidutide in MASH in Late-breaking Poster at AASLD The Liver Meeting® 2025
November 7, 2025

Altimmune Presents AI-Based Analysis of Liver Fibrosis Reduction from IMPACT Phase 2b Trial of Pemvidutide in MASH in Late-breaking Poster at AASLD The Liver Meeting® 2025

Indeterminate GlobeNewswire
Celldex to Present at Upcoming Investor Conferences
November 7, 2025

Celldex to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions